Photo from www.cancer.gov
Jul 3, 2024, 23:45
A four-patient trial testing a unique type of mRNA cancer vaccine – NCI
National Cancer Institute (NCI) shared a post on LinkedIn:
“Recent results from several small clinical trials have suggested it may be possible to develop an effective immunotherapy for glioblastoma. Among them are findings from a four-patient trial testing a unique type of mRNA cancer vaccine.”
Read further.
Source: NCI/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 5, 2024, 03:07
Oct 5, 2024, 02:08
Oct 5, 2024, 02:01
Oct 5, 2024, 01:54
Oct 4, 2024, 19:20
Oct 4, 2024, 19:14